1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	0
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	0
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor	factor	I-NP	NN	I-protein	13	NMOD	0
5	(	(	O	(	O	7	DEP	0
6	VEGF	VEGF	B-NP	NN	B-protein	7	DEP	0
7	)	)	O	)	O	4	NMOD	0
8	in	in	B-PP	IN	O	4	NMOD	0
9	seizures	seizure	B-NP	NNS	O	8	PMOD	0
10	:	:	O	:	O	4	P	0
11	a	a	B-NP	DT	O	13	NMOD	0
12	double-edged	double-edged	I-NP	JJ	O	13	NMOD	0
13	sword	sword	I-NP	NN	O	0	ROOT	0
14	.	.	O	.	O	13	P	0

1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	0
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	0
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor	factor	I-NP	NN	I-protein	8	SUB	0
5	(	(	O	(	O	7	DEP	0
6	VEGF	VEGF	B-NP	NN	B-protein	7	DEP	0
7	)	)	O	)	O	4	NMOD	0
8	is	be	B-VP	VBZ	O	0	ROOT	0
9	a	a	B-NP	DT	O	12	NMOD	0
10	vascular	vascular	I-NP	JJ	B-protein	12	NMOD	0
11	growth	growth	I-NP	NN	I-protein	12	NMOD	0
12	factor	factor	I-NP	NN	I-protein	8	PRD	0
13	which	which	B-NP	WDT	O	12	NMOD	0
14	induces	induce	B-VP	VBZ	O	13	SBAR	17	induces
15	angiogenesis	angiogenesis	B-NP	NN	O	29	NMOD	3	angiogenesis
16	(	(	O	(	O	23	DEP	0
17	the	the	B-NP	DT	O	18	NMOD	0
18	development	development	I-NP	NN	O	23	DEP	2	development
19	of	of	B-PP	IN	O	18	NMOD	0
20	new	new	B-NP	JJ	O	22	NMOD	0
21	blood	blood	I-NP	NN	O	22	NMOD	0
22	vessels	vessel	I-NP	NNS	O	19	PMOD	0
23	)	)	O	)	O	15	NMOD	0
24	,	,	O	,	O	29	P	0
25	vascular	vascular	B-NP	JJ	O	26	NMOD	0
26	permeability	permeability	I-NP	NN	O	29	NMOD	0
27	,	,	O	,	O	29	P	0
28	and	and	O	CC	O	29	NMOD	0
29	inflammation	inflammation	B-NP	NN	O	14	OBJ	0
30	.	.	O	.	O	8	P	0

1	In	In	B-PP	IN	O	7	VMOD	0
2	brain	brain	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	7	P	0
4	receptors	receptor	B-NP	NNS	O	7	SUB	0
5	for	for	B-PP	IN	O	4	NMOD	0
6	VEGF	VEGF	B-NP	NN	B-protein	5	PMOD	0
7	have	have	B-VP	VBP	O	0	ROOT	0
8	been	be	I-VP	VBN	O	7	VC	0
9	localized	localized	B-ADJP	JJ	O	14	NMOD	0
10	to	to	B-PP	TO	O	9	AMOD	0
11	vascular	vascular	B-NP	JJ	O	12	NMOD	0
12	endothelium	endothelium	I-NP	NN	O	10	PMOD	0
13	,	,	O	,	O	9	P	0
14	neurons	neuron	B-NP	NNS	O	8	PRD	0
15	,	,	O	,	O	17	P	0
16	and	and	O	CC	O	17	NMOD	0
17	glia	glia	B-NP	NN	O	7	VMOD	0
18	.	.	O	.	O	7	P	0

1	VEGF	VEGF	B-NP	NN	B-protein	2	SUB	0
2	is	be	B-VP	VBZ	O	0	ROOT	0
3	upregulated	upregulate	I-VP	VBN	O	2	VC	17	upregulated
4	after	after	B-PP	IN	O	3	VMOD	0
5	hypoxic	hypoxic	B-NP	JJ	O	6	NMOD	0
6	injury	injury	I-NP	NN	O	4	PMOD	0
7	to	to	B-PP	TO	O	6	NMOD	0
8	the	the	B-NP	DT	O	9	NMOD	0
9	brain	brain	I-NP	NN	O	7	PMOD	0
10	,	,	O	,	O	2	P	0
11	which	which	B-NP	WDT	O	2	VMOD	0
12	can	can	B-VP	MD	O	11	SBAR	0
13	occur	occur	I-VP	VB	O	12	VC	0
14	during	during	B-PP	IN	O	13	VMOD	0
15	cerebral	cerebral	B-NP	JJ	O	16	NMOD	0
16	ischemia	ischemia	I-NP	NN	O	19	NMOD	0
17	or	or	O	CC	O	19	NMOD	0
18	high-altitude	high-altitude	B-NP	JJ	O	19	NMOD	0
19	edema	edema	I-NP	NN	O	14	PMOD	0
20	,	,	O	,	O	2	P	0
21	and	and	O	CC	O	2	VMOD	0
22	has	have	B-VP	VBZ	O	2	VMOD	0
23	been	be	I-VP	VBN	O	22	VC	0
24	implicated	implicate	I-VP	VBN	O	23	VC	0
25	in	in	B-PP	IN	O	24	VMOD	0
26	the	the	B-NP	DT	O	29	NMOD	0
27	blood-brain	blood-brain	I-NP	NN	O	29	NMOD	0
28	barrier	barrier	I-NP	NN	O	29	NMOD	0
29	breakdown	breakdown	I-NP	NN	O	25	PMOD	6	breakdown
30	associated	associate	B-VP	VBN	O	29	NMOD	0
31	with	with	B-PP	IN	O	30	VMOD	0
32	these	these	B-NP	DT	O	33	NMOD	0
33	conditions	condition	I-NP	NNS	O	31	PMOD	0
34	.	.	O	.	O	2	P	0

1	Given	Give	B-VP	VBN	O	11	VMOD	0
2	its	its	B-NP	PRP$	O	4	NMOD	0
3	recently-described	recently-described	I-NP	JJ	O	4	NMOD	0
4	role	role	I-NP	NN	O	1	OBJ	0
5	as	as	B-PP	IN	O	1	VMOD	0
6	an	an	B-NP	DT	O	8	NMOD	0
7	inflammatory	inflammatory	I-NP	JJ	B-protein	8	NMOD	0
8	mediator	mediator	I-NP	NN	I-protein	5	PMOD	0
9	,	,	O	,	O	11	P	0
10	VEGF	VEGF	B-NP	NN	B-protein	11	SUB	0
11	could	could	B-VP	MD	O	0	ROOT	0
12	also	also	I-VP	RB	O	11	VMOD	0
13	contribute	contribute	I-VP	VB	O	11	VC	0
14	to	to	B-PP	TO	O	13	VMOD	0
15	the	the	B-NP	DT	O	17	NMOD	0
16	inflammatory	inflammatory	I-NP	JJ	O	17	NMOD	0
17	responses	response	I-NP	NNS	O	14	PMOD	0
18	observed	observe	B-VP	VBN	O	17	NMOD	0
19	in	in	B-PP	IN	O	18	VMOD	0
20	cerebral	cerebral	B-NP	JJ	O	21	NMOD	0
21	ischemia	ischemia	I-NP	NN	O	19	PMOD	0
22	.	.	O	.	O	11	P	0

1	After	After	B-PP	IN	O	9	VMOD	0
2	seizures	seizure	B-NP	NNS	O	1	PMOD	0
3	,	,	O	,	O	9	P	0
4	blood-brain	blood-brain	B-NP	NN	O	6	NMOD	0
5	barrier	barrier	I-NP	NN	O	6	NMOD	0
6	breakdown	breakdown	I-NP	NN	O	8	NMOD	6	breakdown
7	and	and	I-NP	CC	O	8	NMOD	0
8	inflammation	inflammation	I-NP	NN	O	9	SUB	0
9	is	be	B-VP	VBZ	O	0	ROOT	0
10	also	also	I-VP	RB	O	9	VMOD	0
11	observed	observe	I-VP	VBN	O	9	VC	0
12	in	in	B-PP	IN	O	11	VMOD	0
13	brain	brain	B-NP	NN	O	12	PMOD	0
14	,	,	O	,	O	11	P	0
15	albeit	albeit	B-ADVP	IN	O	11	VMOD	0
16	on	on	B-PP	IN	O	15	PMOD	0
17	a	a	B-NP	DT	O	19	NMOD	0
18	lower	low	I-NP	JJR	O	19	NMOD	0
19	scale	scale	I-NP	NN	O	16	PMOD	0
20	than	than	B-PP	IN	O	19	NMOD	0
21	that	that	B-NP	DT	O	20	PMOD	0
22	observed	observe	B-VP	VBN	O	21	NMOD	0
23	after	after	B-PP	IN	O	22	VMOD	0
24	stroke	stroke	B-NP	NN	O	23	PMOD	0
25	.	.	O	.	O	9	P	0

1	Recent	Recent	B-NP	JJ	O	2	NMOD	0
2	evidence	evidence	I-NP	NN	O	3	SUB	0
3	has	have	B-VP	VBZ	O	0	ROOT	0
4	suggested	suggest	I-VP	VBN	O	3	VC	0
5	a	a	B-NP	DT	O	6	NMOD	0
6	role	role	I-NP	NN	O	4	OBJ	0
7	for	for	B-PP	IN	O	6	NMOD	0
8	inflammation	inflammation	B-NP	NN	O	7	PMOD	0
9	in	in	B-PP	IN	O	6	NMOD	0
10	seizure	seizure	B-NP	NN	O	11	NMOD	0
11	disorders	disorder	I-NP	NNS	O	9	PMOD	0
12	.	.	O	.	O	3	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	have	have	B-VP	VBP	O	0	ROOT	0
3	described	describe	I-VP	VBN	O	2	VC	0
4	striking	striking	B-NP	JJ	O	5	NMOD	0
5	increases	increase	I-NP	NNS	O	3	OBJ	17	increases
6	in	in	B-PP	IN	O	5	NMOD	0
7	VEGF	VEGF	B-NP	NN	B-protein	8	NMOD	0
8	protein	protein	I-NP	NN	I-protein	6	PMOD	0
9	in	in	B-PP	IN	O	5	NMOD	0
10	both	both	B-NP	CC	O	13	NMOD	0
11	neurons	neuron	I-NP	NNS	B-cell_type	13	NMOD	0
12	and	and	I-NP	CC	O	13	NMOD	0
13	glia	glia	I-NP	NNS	B-cell_type	9	PMOD	0
14	after	after	B-PP	IN	O	5	NMOD	0
15	pilocarpine-induced	pilocarpine-induced	B-NP	JJ	O	17	NMOD	0
16	status	status	I-NP	NN	O	17	NMOD	0
17	epilepticus	epilepticus	I-NP	NN	O	14	PMOD	0
18	in	in	B-PP	IN	O	17	NMOD	0
19	the	the	B-NP	DT	O	20	NMOD	0
20	brain	brain	I-NP	NN	O	18	PMOD	0
21	.	.	O	.	O	2	P	0

1	Increases	Increase	B-NP	NNS	O	4	SUB	17	Increases
2	in	in	B-PP	IN	O	1	NMOD	0
3	VEGF	VEGF	B-NP	NN	B-protein	2	PMOD	0
4	could	could	B-VP	MD	O	0	ROOT	0
5	contribute	contribute	I-VP	VB	O	4	VC	17	contribute
6	to	to	B-PP	TO	O	5	VMOD	0
7	the	the	B-NP	DT	O	12	NMOD	0
8	blood-brain	blood-brain	I-NP	JJ	O	10	NMOD	0
9	barrier	barrier	I-NP	NN	O	10	NMOD	0
10	breakdown	breakdown	I-NP	NN	O	12	NMOD	6	breakdown
11	and	and	I-NP	CC	O	12	NMOD	0
12	inflammation	inflammation	I-NP	NN	O	6	PMOD	0
13	observed	observe	B-VP	VBN	O	12	NMOD	0
14	after	after	B-PP	IN	O	13	VMOD	0
15	seizures	seizure	B-NP	NNS	O	14	PMOD	0
16	.	.	O	.	O	4	P	0

1	However	However	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	VEGF	VEGF	B-NP	NN	B-protein	4	SUB	0
4	has	have	B-VP	VBZ	O	0	ROOT	0
5	also	also	I-VP	RB	O	4	VMOD	0
6	been	be	I-VP	VBN	O	4	VC	0
7	shown	show	I-VP	VBN	O	6	VC	0
8	to	to	I-VP	TO	O	9	VMOD	0
9	be	be	I-VP	VB	O	7	VMOD	0
10	neuroprotective	neuroprotective	B-ADJP	JJ	O	9	PRD	0
11	across	across	B-PP	IN	O	10	AMOD	0
12	several	several	B-NP	JJ	O	14	NMOD	0
13	experimental	experimental	I-NP	JJ	O	14	NMOD	0
14	paradigms	paradigm	I-NP	NNS	O	11	PMOD	0
15	,	,	O	,	O	4	P	0
16	and	and	O	CC	O	4	VMOD	0
17	hence	hence	B-VP	RB	O	4	VMOD	0
18	could	could	I-VP	MD	O	4	VMOD	0
19	potentially	potentially	I-VP	RB	O	18	VMOD	0
20	protect	protect	I-VP	VB	O	18	VC	18	protect
21	vulnerable	vulnerable	B-NP	JJ	B-cell_type	22	NMOD	0
22	cells	cell	I-NP	NNS	I-cell_type	20	OBJ	0
23	from	from	B-PP	IN	O	20	VMOD	0
24	damage	damage	B-NP	NN	O	23	PMOD	6	damage
25	associated	associate	B-VP	VBN	O	24	NMOD	0
26	with	with	B-PP	IN	O	25	VMOD	0
27	seizures	seizure	B-NP	NNS	O	26	PMOD	0
28	.	.	O	.	O	4	P	0

1	Therefore	Therefore	B-ADVP	RB	O	0	ROOT	0
2	,	,	O	,	O	1	P	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	role	role	I-NP	NN	O	2	SUB	0
5	of	of	B-PP	IN	O	4	NMOD	0
6	VEGF	VEGF	B-NP	NN	B-protein	5	PMOD	0
7	after	after	B-SBAR	IN	O	4	DEP	0
8	seizures	seizure	B-NP	NNS	O	9	SUB	0
9	could	could	B-VP	MD	O	7	SBAR	0
10	be	be	I-VP	VB	O	9	VC	0
11	either	either	O	CC	O	14	AMOD	0
12	protective	protective	B-ADJP	JJ	O	14	AMOD	0
13	or	or	I-ADJP	CC	O	14	AMOD	0
14	destructive	destructive	I-ADJP	JJ	O	10	PRD	0
15	.	.	O	.	O	4	P	0

1	Although	Although	B-SBAR	IN	O	19	VMOD	0
2	only	only	B-NP	RB	O	4	NMOD	0
3	further	far	I-NP	JJR	O	4	NMOD	0
4	research	research	I-NP	NN	O	5	SUB	0
5	will	will	B-VP	MD	O	1	SBAR	0
6	determine	determine	I-VP	VB	O	5	VC	0
7	the	the	B-NP	DT	O	9	NMOD	0
8	exact	exact	I-NP	JJ	O	9	NMOD	0
9	nature	nature	I-NP	NN	O	6	OBJ	0
10	of	of	B-PP	IN	O	9	NMOD	0
11	VEGF	VEGF	B-NP	NN	B-protein	12	NMOD	0
12	's	's	B-NP	POS	O	13	NMOD	0
13	role	role	I-NP	NN	O	10	PMOD	0
14	after	after	B-PP	IN	O	13	NMOD	0
15	seizures	seizure	B-NP	NNS	O	14	PMOD	0
16	,	,	O	,	O	19	P	0
17	preliminary	preliminary	B-NP	JJ	O	18	NMOD	0
18	data	datum	I-NP	NNS	O	19	SUB	0
19	indicate	indicate	B-VP	VBP	O	0	ROOT	0
20	that	that	B-SBAR	IN	O	19	VMOD	0
21	VEGF	VEGF	B-NP	NN	B-protein	22	SUB	0
22	plays	play	B-VP	VBZ	O	20	SBAR	0
23	a	a	B-NP	DT	O	25	NMOD	0
24	protective	protective	I-NP	JJ	O	25	NMOD	0
25	role	role	I-NP	NN	O	22	OBJ	0
26	after	after	B-PP	IN	O	22	VMOD	0
27	seizures	seizure	B-NP	NNS	O	26	PMOD	0
28	.	.	O	.	O	19	P	0

